Belvedere Trading’s Immunogen Inc IMGN Stock Holding History

Belvedere Trading’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-15,600	Closed	-$463K	–	1091
2023 Q4	$463K	Buy	15,600 +3,900	+33%	+$77.7K	﹤0.01%	176
2023 Q3	$186K	Sell	11,700 -11,100	-49%	-$185K	﹤0.01%	230
2023 Q2	$430K	Sell	22,800 -16,600	-42%	-$196K	﹤0.01%	163
2023 Q1	$151K	Buy	+39,400	New	+$168K	﹤0.01%	387
2022 Q3	–	Sell	-24,500	Closed	-$125K	–	447
2022 Q2	$125K	Buy	+24,500	New	+$106K	﹤0.01%	232

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Belvedere Trading's IMGN Position: Q1 2024 in Review

Belvedere Trading sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 12,662 shares — an estimated $375K sold.

Belvedere Trading first reported a position in IMGN in Q1 2023 and held it in 4 quarters. The position peaked at $375K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

Belvedere Trading reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
Belvedere Trading sold 12,662 Immunogen Inc shares in Q1 2024, an estimated $375K.
Belvedere Trading first reported a position in Immunogen Inc in Q1 2023 and held it in 4 quarters.
Belvedere Trading's Immunogen Inc position peaked at $375K in Q4 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Belvedere Trading's 13F filing for Q1 2024, filed 9 May 2024.